Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesAlembic sees 1% rise in EBITDA on antidepressant drug nod

SHOW NAMES

Trending Topics

business

Alembic sees 1% rise in EBITDA on antidepressant drug nod

Alembic Pharmaceuticals expects 100 basis points improvement in its EBITDA as it has earned exclusive rights to sell Pristiq generic tablets for 24 Months.

first published: Mar 6, 2013 01:25 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347